Hepatitis C virus genotype 4: Genotype 1's little brother.

about

Response Tailored Protocol Versus the Fixed 12Weeks Course of Dual Sofosbuvir/Daclatasvir Treatment in Egyptian Patients With Chronic Hepatitis C Genotype-4 Infection: A Randomized, Open-label, Non-inferiority Trial.

P2860

Q39610676-391A2A4B-29D9-4CD1-98C9-CDFBF753E570

P2860

Hepatitis C virus genotype 4: Genotype 1's little brother.

Item

http://www.wikidata.org/entity/Q39025320

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Hepatitis C virus genotype 4: Genotype 1's little brother.

@en

Hepatitis C virus genotype 4: Genotype 1's little brother.

@nl

type

Item

label

Hepatitis C virus genotype 4: Genotype 1's little brother.

@en

Hepatitis C virus genotype 4: Genotype 1's little brother.

@nl

prefLabel

Hepatitis C virus genotype 4: Genotype 1's little brother.

@en

Hepatitis C virus genotype 4: Genotype 1's little brother.

@nl

P1476

Hepatitis C virus genotype 4: Genotype 1's little brother

@en

P2093

J Llaneras

http://www.w3.org/2001/XMLSchema#string

M Buti

http://www.w3.org/2001/XMLSchema#string

M Riveiro-Barciela

http://www.w3.org/2001/XMLSchema#string

P2860

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

Sofosbuvir for previously untreated chronic hepatitis C infection

Ledipasvir and sofosbuvir for hepatitis C genotype 4: a proof-of-concept, single-centre, open-label phase 2a cohort study.

12 Weeks of Daclatasvir in Combination With Sofosbuvir for HIV-HCV Coinfection (ALLY-2 Study): Efficacy and Safety by HIV Combination Antiretroviral Regimens.

Ledipasvir and Sofosbuvir for HCV in Patients Coinfected with HIV-1.

Management of hepatitis C virus genotype 4: recommendations of an international expert panel.

Ombitasvir, paritaprevir co-dosed with ritonavir, dasabuvir, and ribavirin for hepatitis C in patients co-infected with HIV-1: a randomized trial.

Hepatitis C Virus Resistance to Direct-Acting Antiviral Drugs in Interferon-Free Regimens.

Ombitasvir, paritaprevir, and ritonavir plus ribavirin in adults with hepatitis C virus genotype 4 infection and cirrhosis (AGATE-I): a multicentre, phase 3, randomised open-label trial.

P304

4-12

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/JVH.12620

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Rafael Esteban

P577

2016-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27905173

http://www.w3.org/2001/XMLSchema#string

Hepatitis C virus genotype 4: Genotype 1's little brother.

about

P2860

P2860

Hepatitis C virus genotype 4: Genotype 1's little brother.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698